Ceri Hirst

921 total citations
28 papers, 573 citations indexed

About

Ceri Hirst is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Ceri Hirst has authored 28 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in Ceri Hirst's work include Hemoglobinopathies and Related Disorders (10 papers), Pneumonia and Respiratory Infections (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Ceri Hirst is often cited by papers focused on Hemoglobinopathies and Related Disorders (10 papers), Pneumonia and Respiratory Infections (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Ceri Hirst collaborates with scholars based in United Kingdom, United States and Switzerland. Ceri Hirst's co-authors include Shirley Owusu‐Ofori, Lorna M. Williamson, E. Graham Davies, Nancy A. Dower, Richard Lottenberg, Beth Sherrill, Anat Loewenstein, Mali Okada, James Talks and Jane Barratt and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cochrane Database of Systematic Reviews.

In The Last Decade

Ceri Hirst

26 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ceri Hirst United Kingdom 15 176 147 128 122 74 28 573
Eva Salgado Spain 12 104 0.6× 141 1.0× 101 0.8× 25 0.2× 45 0.6× 22 804
Katie Bechman United Kingdom 16 101 0.6× 184 1.3× 35 0.3× 14 0.1× 126 1.7× 58 993
Supratik Basu United Kingdom 16 100 0.6× 483 3.3× 53 0.4× 11 0.1× 33 0.4× 47 836
Álvaro Danza Uruguay 10 32 0.2× 85 0.6× 128 1.0× 14 0.1× 35 0.5× 35 763
Alice J. Cohen United States 14 170 1.0× 446 3.0× 47 0.4× 6 0.0× 57 0.8× 42 868
Ahsan Wahab United States 10 47 0.3× 91 0.6× 39 0.3× 10 0.1× 59 0.8× 58 384
Somedeb Ball United States 15 114 0.6× 160 1.1× 28 0.2× 7 0.1× 162 2.2× 99 802
Veerle Vanvoorden Belgium 13 39 0.2× 121 0.8× 55 0.4× 6 0.0× 119 1.6× 24 1.2k
Z. Tellier France 15 87 0.5× 550 3.7× 26 0.2× 11 0.1× 45 0.6× 31 1.1k
Asha Shah India 10 41 0.2× 36 0.2× 26 0.2× 26 0.2× 8 0.1× 35 360

Countries citing papers authored by Ceri Hirst

Since Specialization
Citations

This map shows the geographic impact of Ceri Hirst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ceri Hirst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ceri Hirst more than expected).

Fields of papers citing papers by Ceri Hirst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ceri Hirst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ceri Hirst. The network helps show where Ceri Hirst may publish in the future.

Co-authorship network of co-authors of Ceri Hirst

This figure shows the co-authorship network connecting the top 25 collaborators of Ceri Hirst. A scholar is included among the top collaborators of Ceri Hirst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ceri Hirst. Ceri Hirst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Talks, James, Vincent Daïen, Paul Mitchell, et al.. (2022). The Patient Voice in Neovascular Age-Related Macular Degeneration: Findings from a Qualitative Study. Ophthalmology and Therapy. 12(1). 561–575. 6 indexed citations
2.
Okada, Mali, Paul Mitchell, Robert P. Finger, et al.. (2020). Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration. Ophthalmology. 128(2). 234–247. 126 indexed citations
3.
Krueger, Whitney S., Mary S. Anthony, Andrea V. Margulis, et al.. (2017). Evaluating the Safety of Medication Exposures During Pregnancy: A Case Study of Study Designs and Data Sources in Multiple Sclerosis. Drugs - Real World Outcomes. 4(3). 139–149. 14 indexed citations
4.
Hirst, Ceri, et al.. (2016). Health Status in Patients with Severe Haemophilia a According to Treatment Regimen and Age. Value in Health. 19(7). A592–A593. 1 indexed citations
5.
Eccles, Diana, Judith Balmañà, B. Ehlken, et al.. (2016). Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review. Advances in Therapy. 33(2). 129–150. 33 indexed citations
6.
Hirst, Ceri, James Ryan, Ozgur Tunceli, Bingcao Wu, & David M. Kern. (2014). Cost Profile of Patients with Gastric Cancer Using United States Administrative Claims Data. Value in Health. 17(3). A78–A78. 1 indexed citations
7.
Hirst, Ceri, Amit Allahabadia, & John Cosgrove. (2014). The adult patient with hyponatraemia. BJA Education. 15(5). 248–252.
8.
Hirst, Ceri & Shirley Owusu‐Ofori. (2014). Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database of Systematic Reviews. CD003427–CD003427. 30 indexed citations
9.
Owusu‐Ofori, Shirley & Ceri Hirst. (2013). Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease. Cochrane Database of Systematic Reviews. CD003425–CD003425. 15 indexed citations
10.
Hirst, Ceri & Lorna M. Williamson. (2012). Preoperative blood transfusions for sickle cell disease. Cochrane Database of Systematic Reviews. 1. CD003149–CD003149. 20 indexed citations
11.
Hirst, Ceri & Shirley Owusu‐Ofori. (2012). Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database of Systematic Reviews. CD003427–CD003427. 18 indexed citations
12.
Hirst, Ceri, et al.. (2012). Epidemiology of castration resistant prostate cancer: A longitudinal analysis using a UK primary care database. Cancer Epidemiology. 36(6). e349–e353. 35 indexed citations
13.
Hirst, Ceri, Brian Calingaert, Richard H. Stanford, & Jordi Castellsagué. (2010). Use of Long-Acting β-Agonists and Inhaled Steroids in Asthma: Meta-analysis of Observational Studies. Journal of Asthma. 47(4). 439–446. 21 indexed citations
14.
15.
Sherrill, Beth, Mayur M. Amonkar, Yun Wu, et al.. (2008). Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer. British Journal of Cancer. 99(10). 1572–1578. 62 indexed citations
16.
Sherrill, Beth, et al.. (2008). Disease progression as a predictor of overall survival in metastatic breast cancer: a meta-analysis. European Journal of Cancer Supplements. 6(7). 216–216. 2 indexed citations
17.
Hirst, Ceri, Suzanne F. Cook, Wanju S. Dai, Susana Perez‐Gutthann, & Elizabeth Andrews. (2006). A call for international harmonization in therapeutic risk management. Pharmacoepidemiology and Drug Safety. 15(12). 839–849. 21 indexed citations
18.
Cohen, Alexander T., et al.. (2005). Meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery. British journal of surgery. 92(11). 1335–1344. 17 indexed citations
19.
Davies, E. Graham, Ceri Hirst, Richard Lottenberg, & Nancy A. Dower. (2004). Pneumococcal vaccines for sickle cell disease. Cochrane Database of Systematic Reviews. 2012(2). CD003885–CD003885. 59 indexed citations
20.
Owusu‐Ofori, Shirley & Ceri Hirst. (2002). Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease. Cochrane Database of Systematic Reviews. CD003425–CD003425. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026